Spanish Red Biotech Pipeline

Oryzon

Iadademstat (ORY-1001) - Selective LSD1 inhibitor

Type: Biodrugs/ Drugs
Therapeutic area:
Indication: AML - 1L Elderly / Unfit Clinical Trial "ALICE" (Combo w azacitidine) Ongoing - fully enrolled 2H22 EHA/ASH Final Data
Phase: 2Phase II, 1Phase I, 2Regulatory Preclinical, 1Non Regulatory Preclinical